Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20141
20151
20162
20192
20204
20212
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed5
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AHS Cancer Control Alberta1
Amgen1
BioNTech SE1
Bold Therapeutics, Inc.1
Bristol-Myers Squibb1
CARsgen Therapeutics Co., Ltd.1
LigaChem Biosciences, Inc.1
MacroGenics1
Marengo Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms20
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms6
Esophageal Neoplasms6
Neoplasms6
Pancreatic Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Urinary Bladder Neoplasms5
Uterine Cervical Neoplasms5
Biliary Tract Neoplasms4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.